Accounts Submission


CILL DARA BLOODSTOCK LTD

Company Registration Number:
09877667 (England and Wales)

Unaudited statutory accounts for the year ended 11 March 2024

Period of accounts

Start date: 01 November 2023

End date: 11 March 2024

CILL DARA BLOODSTOCK LTD

Contents of the Financial Statements

for the Period Ended 11 March 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Additional notes - 7

CILL DARA BLOODSTOCK LTD

Company Information

for the Period Ended 11 March 2024




Director: DARREN TURNER
SIMON COX
Registered office: 2
High Trees Road
Reigate
England
RH2 7EJ
Company Registration Number: 09877667 (England and Wales)

CILL DARA BLOODSTOCK LTD

Profit and Loss Account

for the Period Ended 11 March 2024


Notes
4 months to
11 Mar 2024
£

2023
£
Turnover 54,250 32,000
Cost of sales ( 49,930 ) ( 17,168 )
Gross Profit or (Loss) 4,320 14,832
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 0 ) ( 0 )
Other operating income 0 0
Operating Profit or (Loss) 4,320 14,832
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges ( 0 ) ( 0 )
Profit or (Loss) Before Tax 4,320 14,832
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period 4,320 14,832

The notes form part of these financial statements

CILL DARA BLOODSTOCK LTD

Balance sheet

As at 11 March 2024


Notes
4 months to
11 Mar 2024
£

2023
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 98,604 99,250
Total current assets: 98,604 99,250
Net current assets (liabilities): 98,604 99,250
Total assets less current liabilities: 98,604 99,250
Total net assets (liabilities): 98,604 99,250

The notes form part of these financial statements

CILL DARA BLOODSTOCK LTD

Balance sheet continued

As at 11 March 2024


Notes
4 months to
11 Mar 2024
£

2023
£
Capital and reserves
Called up share capital: 98,604 99,250
Shareholders funds: 98,604 99,250

For the year ending 11 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 April 2024
And Signed On Behalf Of The Board By:

Name: SIMON COX
Status: Director

The notes form part of these financial statements

CILL DARA BLOODSTOCK LTD

Notes to the Financial Statements

for the Period Ended 11 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CILL DARA BLOODSTOCK LTD

Notes to the Financial Statements

for the Period Ended 11 March 2024

  • 2. Employees

    4 months to
    11 Mar 2024

    2023
    Average number of employees during the period 0 0

CILL DARA BLOODSTOCK LTD

Notes to the Financial Statements

for the Period Ended 11 March 2024

  • 3. Off balance sheet disclosure

    No